Importantly, mounting evidence collected over the past decade indicates that the etiology of T2D includes an autoimmune component that initiates an inflammation affecting pancreatic islet β cells [8,28-32], which provides new insight into the mechanism and potential treatment of insulin resistance through immune modulation. Here, INS is linked to type 2 diabetes mellitus.